The oncogenic properties of the HMG-I gene family.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10945639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family

  2005cited by this paper
• High-mobility-group proteins and cancer—an emerging link

  2005cited by this paper
• Translocations in Solid Tumors

  2002cited by this paper
• HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene

  2000cited by this paper
• Induction of High Mobility Group-I(Y) Protein by Endotoxin and Interleukin-1β in Vascular Smooth Muscle Cells

  1999cited by this paper
• Function of the c-Myc oncogenic transcription factor.

  1999cited by this paper
• Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins

  1999cited by this paper
• Is Hmgic rearranged due to cryptic paracentric inversion of 12q in karyotypically normal uterine leiomyomas?

  1999cited by this paper
• The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis.

  1999cited by this paper
• Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase.

  1999cited by this paper
• The HMG-I(Y) A·T-hook Peptide Motif Confers DNA-binding Specificity to a Structured Chimeric Protein*

  1999cited by this paper
• Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes.

  1998cited by this paper
• In vivo analysis of scaffold‐associated regions in Drosophila: a synthetic high‐affinity SAR binding protein suppresses position effect variegation

  1998cited by this paper
• Chromosomal translocations in benign tumors: the HMGI proteins.

  1998cited by this paper
• Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts

  1998cited by this paper
• Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years.

  1998cited by this paper
• Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma.

  1998cited by this paper
• Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas

  1998cited by this paper
• Amplification and expression of the HMGIC gene in a benign endometrial polyp

  1998cited by this paper
• Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes.

  1998cited by this paper
• Cloning of a breakpoint cluster region on chromosome 14 in uterine leiomyoma.

  1998cited by this paper
• Expression of HMGI‐C, a member of the high mobility group protein family, in a subset of breast cancers: Relationship to histologic grade

  1997cited by this paper
• An HMG I/Y-containing repressor complex and supercoiled DNA topology are critical for long-range enhancer-dependent transcription in vitro.

  1997cited by this paper
• Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene

  1997cited by this paper
• c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

  1997influential reference
• From chromosome aberrations to the high mobility group protein gene family: evidence for a common genetic denominator in benign solid tumor development.

  1997cited by this paper
• HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality.

  1997cited by this paper
• The high mobility group I-C gene (HMGI-C): polymorphism and genetic localization

  1996cited by this paper
• Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps.

  1996cited by this paper
• A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.

  1996cited by this paper
• Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations.

  1996cited by this paper
• Translocations in solid tumours.

  1996cited by this paper
• A retrospective study of high mobility group protein I(Y) as progressiona marker for prostate cancer determined by in situ hybridization

  1996cited by this paper
• An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12.

  1996cited by this paper
• Genomic structure and expression of the murine Hmgi-c gene.

  1996cited by this paper
• High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

  1996cited by this paper
• Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality.

  1996cited by this paper
• HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors.

  1996cited by this paper
• Multivalent DNA-binding properties of the HMG-1 proteins.

  1996cited by this paper
• Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains.

  1995cited by this paper
• SARs are cis DNA elements of chromosome dynamics: synthesis of a SAR repressor protein.

  1995cited by this paper
• Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C

  1995cited by this paper
• The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.

  1995cited by this paper
• Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells

  1995cited by this paper
• Identification of novel cellular genes transcriptionally suppressed by v-src.

  1995cited by this paper
• Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome.

  1995cited by this paper
• Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y).

  1995cited by this paper
• A mammalian delayed-early response gene encodes HNP36, a novel, conserved nucleolar protein.

  1995cited by this paper
• Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins

  1995cited by this paper
• Molecular characterization of mar, a multiple aberration region on human chromosome segment 12q13‐q15 implicated in various solid tumors

  1995cited by this paper
• Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours

  1995cited by this paper
• The non‐histone chromosomal protein HMG‐I(Y) contributes to repression of the immunoglobulin heavy chain germ‐line ε RNA promoter

  1995cited by this paper
• Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter

  1994cited by this paper
• Short peptide fragments derived from HMG-I/Y proteins bind specifically to the minor groove of DNA.

  1994cited by this paper
• Chromosomal translocations in human cancer

  1994cited by this paper
• A striking similarity in the organization of the E-selectin and beta interferon gene promoters

  1994cited by this paper
• Expression and cDNA cloning of human HMGI-C phosphoprotein.

  1994cited by this paper
• Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter.

  1994cited by this paper
• The high mobility group protein HMG I(Y) is an essential structural component of a virus-inducible enhancer complex.

  1993cited by this paper
• Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.

  1993cited by this paper
• High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse.

  1993cited by this paper
• Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene.

  1993cited by this paper
• SAR‐dependent mobilization of histone H1 by HMG‐I/Y in vitro: HMG‐I/Y is enriched in H1‐depleted chromatin.

  1993cited by this paper
• Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.

  1993cited by this paper
• Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells.

  1993cited by this paper
• Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements.

  1993cited by this paper
• Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter.

  1993cited by this paper
• The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.

  1992cited by this paper
• Chromosomal localization of the murine gene and two related sequences encoding high-mobility-group I and Y proteins.

  1992cited by this paper
• Sequence-specific binding of HMG-I(Y) to the proximal promoter of the gp91-phox gene.

  1992cited by this paper
• A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-beta) gene regulation

  1992cited by this paper
• Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.

  1992cited by this paper
• The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene.

  1992cited by this paper
• The High Mobility Group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene

  1992cited by this paper
• Sequence-specific binding of HMG-I (Y) to the proximal promoter of the gp91-phox gene.

  1992cited by this paper
• Growth factor-induced delayed early response genes

  1992cited by this paper
• Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.

  1991cited by this paper
• Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C protein.

  1991cited by this paper
• cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes.

  1991cited by this paper
• Structural features of the HMG chromosomal proteins and their genes.

  1990cited by this paper
• The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure.

  1990cited by this paper
• Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures.

  1989cited by this paper
• Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y).

  1988cited by this paper
• Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v‐ras and v‐mos oncogenes and by cotransfection with c‐myc and polyoma middle T genes.

  1987cited by this paper
• Neoplastic transformation by the human gene N-myc

  1987cited by this paper
• Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts.

  1987cited by this paper
• A mammalian high mobility group protein recognizes any stretch of six A.T base pairs in duplex DNA.

  1986cited by this paper
• Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus.

  1985cited by this paper
• Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals.

  1984cited by this paper
• On the presence of two new high mobility group‐like proteins in HeLa S3 cells

  1983cited by this paper

• High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression

  2025cites this paper
• Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling

  2023cites this paper
• HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition

  2022cites this paper
• HMGA1 Chromatin Regulators Induce Transcriptional Networks Involved in GATA2 and Proliferation During MPN Progression.

  2022cites this paper
• HMGA1 Induction of miR-103/107 Forms a Negative Feedback Loop to Regulate Autophagy in MPTP Model of Parkinson’s Disease

  2021cites this paper
• HMGA1 induces EZH2 overexpression in human B-cell lymphomas.

  2021cites this paper
• HMGA2 as a Critical Regulator in Cancer Development

  2021cites this paper
• HMGA1 Is a Potential Driver of Preeclampsia Pathogenesis by Interference with Extravillous Trophoblasts Invasion

  2021cites this paper
• Modulation of Vascular Smooth Muscle Cell Phenotype by High Mobility Group AT-Hook 1

  2021cites this paper
• High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia

  2020cites this paper
• HMGA Proteins in Hematological Malignancies

  2020cites this paper
• HMGA Genes and Proteins in Development and Evolution

  2020cites this paper
• Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression.

  2019cites this paper
• Oncological role of HMGA2 (Review).

  2019cites this paper
• High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer

  2019cites this paper
• HMGA and Cancer: A Review on Patent Literatures.

  2019cites this paper
• High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.

  2018cites this paper
• Anticancer activity of HMGA 1 promoter targeting triplex forming oligonucleotide in HeLa cell line

  2018cites this paper
• HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis

  2018cites this paper
• Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets

  2018cites this paper
• Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2.

  2018cites this paper
• Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.

  2018cites this paper
• Triplex forming oligonucleotides targeted to hmga1 selectively inhibit its expression and induce apoptosis in human cervical cancer

  2017cites this paper
• HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models1

  2016cites this paper
• In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug

  2016cites this paper
• The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.

  2016cites this paper
• The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

  2016influential citation
• Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells

  2016cites this paper
• MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2

  2016cites this paper
• CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer

  2016cites this paper
• Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.

  2016cites this paper
• HMGA1-pseudogenes and cancer

  2016cites this paper
• High Mobility Group A2 protects cancer cells against telomere dysfunction

  2016cites this paper
• Fra-1 et Fra-2 dans les cancers du sein triple négatifs : mécanismes transcriptionnels et identification de cibles thérapeutiques potentielles

  2016cites this paper
• HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer.

  2015cites this paper
• Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes

  2015cites this paper
• Regulatory modules discovery and mesenchymal stem cells characterization from high-throughput cancer genomics data

  2015cites this paper
• HMGA 1 : a choice of symmetry

  2015cites this paper
• HMGA1 overexpression is associated with a particular subset of human breast carcinomas

  2015cites this paper
• Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas

  2015cites this paper
• The high mobility group A1 molecular switch: turning on cancer – can we turn it off?

  2014cites this paper
• HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs

  2014cites this paper
• Generation and Characterisation of a Canine EGFP-HMGA2 Prostate Cancer In Vitro Model

  2014cites this paper
• Hmga1/Hmga2 double knock-out mice display a “superpygmy” phenotype

  2014cites this paper
• СРАВНИТЕЛЬНЫЙ ПРОТЕОМНЫЙ АНАЛИЗ КОНДЕНСАТА ВЫДЫХАЕМОГО ВОЗДУХА У ПАЦИЕНТОВ С РАКОМ ЛЕГКОГО МЕТОДОМ МАСС-СПЕКТРОМЕТРИИ ВЫСОКОГО РАЗРЕШЕНИЯ

  2014cites this paper
• HMGA1: A choice of symmetry

  2014cites this paper
• MiR-1423 p Functions as a Potential Tumor Suppressor in Human Osteosarcoma by Targeting HMGA 1

  2014cites this paper
• MiR-142-3p Functions as a Potential Tumor Suppressor in Human Osteosarcoma by Targeting HMGA1

  2014cites this paper
• Regulation of nonmuscle myosin II during 3-methylcholanthrene induced dedifferentiation of C2C12 myotubes.

  2014cites this paper
• HMGA proteins as modulators of chromatin structure during transcriptional activation

  2013cites this paper
• The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR‐603 and miR‐10b expression

  2013cites this paper
• The Wnt/β‐catenin/T‐cell factor 4 pathway up‐regulates high‐mobility group A1 expression in colon cancer

  2013cites this paper
• Hitting the bull’s eye: targeting HMGA1 in cancer stem cells

  2013cites this paper
• HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness

  2013cites this paper
• HMGA2 inhibits apoptosis through interaction with ATR/CHK1 signaling complex in human cancer cells

  2013cites this paper
• HMGA2 and high-grade serous ovarian carcinoma

  2013cites this paper
• Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis

  2013cites this paper
• Overexpression of High Mobility Group A1 Protein in Human Uveal Melanomas: Implication for Prognosis

  2013cites this paper
• HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma

  2012cites this paper
• Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma

  2012cites this paper
• High mobility group A-interacting proteins in cancer: focus on chromobox protein homolog 7, homeodomain interacting protein kinase 2 and PATZ

  2012cites this paper
• HMGA1 Reprograms Somatic Cells into Pluripotent Stem Cells by Inducing Stem Cell Transcriptional Networks

  2012cites this paper
• Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells.

  2012cites this paper
• High mobility group A1 and cancer: potential biomarker and therapeutic target.

  2012influential citation
• The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.

  2012cites this paper
• Critical roles of the cAMP‐responsive element‐binding protein‐mediated pathway in disorganized epithelial phenotypes caused by mitochondrial dysfunction

  2012cites this paper
• Expression and role of HMGA1 in renal cell carcinoma.

  2012cites this paper
• PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.

  2012cites this paper
• The high‐mobility group A1‐estrogen receptor β nuclear interaction is impaired in human testicular seminomas

  2012influential citation
• HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells

  2012cites this paper
• Chapter 15 – Prolactinoma

  2011cites this paper
• High-Mobility Group A2 Protein Modulates hTERT Transcription To Promote Tumorigenesis

  2011cites this paper
• Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia

  2011cites this paper
• HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis

  2011cites this paper
• Coordinate activation of inflammatory gene networks, alveolar destruction and neonatal death in AKNA deficient mice

  2011cites this paper
• Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.

  2011cites this paper
• Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice.

  2011cites this paper
• HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents

  2011cites this paper
• Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer.

  2010cites this paper
• High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.

  2010cites this paper
• HMG Nuclear Proteins: Linking Chromatin Structure to Cellular Phenotype

  2010cites this paper
• HMGA and cancer.

  2010cites this paper
• HMGA1 protein expression in familial breast carcinoma patients.

  2010cites this paper
• Nuclear functions of the HMG proteins.

  2010cites this paper
• The high mobility group A1 gene: transforming inflammatory signals into cancer?

  2010cites this paper
• Role of the high mobility group A proteins in the regulation of pituitary cell cycle.

  2010cites this paper
• Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein.

  2010cites this paper
• PONTIFÍCIA UNIVERSIDADE CATÓLICA DO RIO GRANDE DO SUL INSTITUTO DE GERIATRIA E GERONTOLOGIA PROGRAMA DE PÓS-GRADUAÇÃO EM GERONTOLOGIA BIOMÉDICA

  2009cites this paper
• High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.

  2009cites this paper
• HMGA1 Correlates with Advanced Tumor Grade and Decreased Survival in Pancreatic Ductal Adenocarcinoma

  2009cites this paper
• HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.

  2009cites this paper
• Inhibition of HMGA2 binding to DNA by netropsin

  2009cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2009cites this paper
• Upregulation of MMP-2 by HMGA1 Promotes Transformation in Undifferentiated, Large-Cell Lung Cancer

  2009influential citation
• HMGA1 Levels Influence Mitochondrial Function and Mitochondrial DNA Repair Efficiency

  2009cites this paper
• HMGA Proteins Upregulate CCNB 2 Gene in Mouse and Human Pituitary Adenomas

  2009cites this paper
• The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?

  2008cites this paper
• Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts

  2008cites this paper
• HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma

  2008cites this paper
• The HMGA proteins: a myriad of functions (Review).

  2008cites this paper